Product information and disease descriptionPlace of product in therapyApproaches to treatment
Current treatment options and standard of care
97 evidence topics · 34 sources
BIM-IOL System
Open-angle glaucoma or ocular hypertension
- Manufacturer
- SpyGlass Pharma
- Regulatory submission
- NDA planned for 2028
- Launch
- Not announced
- Last updated